GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer

Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of total lung cancers; 40% to 60% of NSCLC patients die of cancer recurrence after cancer resection. Since GLK (also named MAP4K3) induces activation of NF-κB, which contributes to tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chung-Ping, Chuang, Huai-Chia, Lee, Ming-Ching, Tsou, Hsiao-Hui, Lee, Li-Wen, Li, Ju-Pi, Tan, Tse-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173093/
https://www.ncbi.nlm.nih.gov/pubmed/27203390
http://dx.doi.org/10.18632/oncotarget.9410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173093/
https://www.ncbi.nlm.nih.gov/pubmed/27203390
http://dx.doi.org/10.18632/oncotarget.9410

Ejemplares similares